APELLIS PHARMACEUTICALS INC's ticker is APLS and the CUSIP is 03753U106. A total of 177 filers reported holding APELLIS PHARMACEUTICALS INC in Q1 2021. The put-call ratio across all filers is 0.39 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $2,294 | -9.4% | 60,304 | +116.9% | 0.11% | -1.8% |
| Q2 2023 | $2,532 | -10.1% | 27,799 | -34.9% | 0.11% | -17.3% |
| Q1 2023 | $2,816 | +63.9% | 42,699 | +28.5% | 0.13% | +40.0% |
| Q4 2022 | $1,718 | -99.9% | 33,231 | 0.0% | 0.10% | -30.7% |
| Q3 2022 | $2,270,000 | +60.0% | 33,231 | +5.9% | 0.14% | +28.0% |
| Q2 2022 | $1,419,000 | +37.8% | 31,384 | +54.9% | 0.11% | +59.7% |
| Q1 2022 | $1,030,000 | +196.0% | 20,263 | +175.1% | 0.07% | +55.8% |
| Q4 2021 | $348,000 | -9.6% | 7,367 | -18.0% | 0.04% | -65.0% |
| Q1 2021 | $385,000 | -79.2% | 8,979 | -72.3% | 0.12% | -76.7% |
| Q4 2020 | $1,853,000 | +72.7% | 32,403 | -8.9% | 0.53% | +54.8% |
| Q3 2020 | $1,073,000 | -31.7% | 35,575 | -26.1% | 0.34% | -36.1% |
| Q2 2020 | $1,572,000 | +17.7% | 48,135 | -3.5% | 0.53% | -5.2% |
| Q1 2020 | $1,336,000 | – | 49,885 | – | 0.56% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| AJU IB Investment Co., Ltd. | 1,114,962 | $63,776,000 | 24.13% |
| Octagon Capital Advisors LP | 548,374 | $31,367,000 | 10.87% |
| Ghost Tree Capital, LLC | 325,000 | $18,590,000 | 4.14% |
| Burrage Capital Management LLC | 81,357 | $4,654,000 | 3.55% |
| Aufman Associates Inc | 53,642 | $3,068,000 | 2.75% |
| ACUTA CAPITAL PARTNERS, LLC | 167,054 | $9,555,000 | 2.60% |
| Cormorant Asset Management, LP | 1,866,108 | $106,741,000 | 2.54% |
| Tri Locum Partners LP | 121,409 | $6,945,000 | 2.52% |
| venBio Partners LLC | 490,471 | $28,055,000 | 2.48% |
| HHLR ADVISORS, LTD. | 5,028,289 | $287,618,000 | 2.29% |